Topical corticosteroid offers effective intervention
February 1st 2010For patients who suffer with moderate to severe signs and symptoms of seasonal or perennial allergic conjunctivitis, loteprednol etabonate 0.2% is a safe and well-tolerated therapeutic option that can provide rapid clinical improvement, according to an expert.
Review key concepts in glaucoma evaluation, management
January 1st 2010Some critical issues to consider when diagnosing glaucoma are the recognition of an association between sleep dysfunction and glaucoma, the effect of corneal thickness on the accuracy of intraocular pressure (IOP) measurements, and the importance of first determining optic disk size when evaluating cup-to-disc ratio.
Removing benzalkonium chloride may not reduce irritation
January 1st 2010Switching to another prostaglandin analogue that does not contain benzalkonium chloride may not be the answer for managing patients complaining of dryness and irritation while using latanoprost 0.005%, according to the results of a prospective, double-masked, randomized clinical study by eye-care professionals at Lackland Air Force Base.
Quality of life assessment is part of treatment plan
January 1st 2010Optimizing care of patients with ocular hypertension and glaucoma requires understanding that glaucoma is a chronic, progressive disease existing along a continuum both in terms of clinical severity and its impact on quality of life.
Study shows positive impact of mandatory preschool eye exams
January 1st 2010Mandatory preschool eye examination and treatment in Kentucky has had a positive impact on early academic performance, particularly in school districts in which residents are of a lower socioeconomic status, according to new research.